CBD Life Sciences Inc.
CBDL
$0.0004
$0.000.00%
06/30/2022 | 03/31/2022 | ||||
---|---|---|---|---|---|
Revenue | 5.56% | 109.87% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 5.56% | 109.87% | |||
Cost of Revenue | -16.59% | 65.94% | |||
Gross Profit | 26.36% | 181.18% | |||
SG&A Expenses | -25.29% | -78.11% | |||
Depreciation & Amortization | 2.26% | -- | |||
Other Operating Expenses | -17.86% | -15.15% | |||
Total Operating Expenses | -23.49% | -75.50% | |||
Operating Income | 28.29% | 78.62% | |||
Income Before Tax | 28.29% | 78.62% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | 28.29% | 78.62% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 28.29% | 78.62% | |||
EBIT | 28.29% | 78.62% | |||
EBITDA | 30.26% | -- | |||
EPS Basic | 28.57% | 81.74% | |||
Normalized Basic EPS | 30.77% | 81.94% | |||
EPS Diluted | 28.57% | 81.74% | |||
Normalized Diluted EPS | 30.77% | 81.94% | |||
Average Basic Shares Outstanding | 0.00% | 17.95% | |||
Average Diluted Shares Outstanding | 0.00% | 17.95% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |